Futures Mixed as Inflation Looms; Nvidia Declines Premarket
"Futures mixed as investors await inflation data; Nvidia slips, Fed's rate cut predictions diverge from market expectations. Key premarket movers ...
- Latest
- Trending
"Futures mixed as investors await inflation data; Nvidia slips, Fed's rate cut predictions diverge from market expectations. Key premarket movers ...
Invest-NL’s Deep Tech Fund injects $26M into Qblox, boosting Dutch ambitions in global quantum technology. The Netherlands eyes leadership in ...
"Numinus Wellness acquires MedBright AI, merging AI with psychedelics for advanced mental health care and expanded services in the U.S."
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
AbbVie sets quarterly dividend at $1.55 per share, showcasing financial health and strategic growth. Recent acquisitions bolster positive outlook.
Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...
European stocks dipped Friday as tech and banks struggled amidst Carlsberg's slump and weak economic data, despite UK retail sales ...
Jazz Pharmaceuticals hits a hurdle as its essential tremor drug trial misses primary endpoint. Awaiting Parkinson's trial results for future ...
Esperion's stock downgraded by BofA due to rising competition from Merck's PCSK9 inhibitors. Analysts weigh in on efficacy and market ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.